NCT00368368View on ClinicalTrials.gov

A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Diabetes Mellitus Type 2
Interventions
DRUG

GK Activator (2)

100mg po

Trial Locations (5)

75247

Dallas

78229

San Antonio

78758

Austin

90630

Cypress

833 01

Bratislava

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00368368 - A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes. | Biotech Hunter | Biotech Hunter